ABOUT US

Our Department

Our Department

Department of Molecular & Medical Pharmacology (DMMP)

The Department of Molecular and Medical Pharmacology (DMMP) is a combined basic science and clinical department. The DMMP integrates mathematics, engineering, physical, biological and medical sciences to achieve together advances that we cannot achieve individually in three overall areas: (1) understanding biology of disease, (2) developing new molecular diagnostics and (3) developing new molecular and cellular therapeutics.

  • Department of Molecular & Medical PharmacologyDepartment of Molecular & Medical Pharmacology
  • Crump Institute for Molecular ImagingCrump Institute for Molecular Imaging

    The Crump Institute for Molecular Imaging in the Department of Molecular and Medical Pharmacology brings together faculty, students, and staff with a variety of backgrounds - physics, mathematics, engineering, biology, chemistry, and medicine - to pursue innovative technologies and science to accelerate our understanding of biology and medicine. Trailblazing technology programs, linked by systems biology, microfluidics, nanotechnology, and molecular imaging, provide the tools to conduct integrated science in a unique, interdisciplinary setting. The faculty, students and staff of the Crump Institute have established a rich history of invention and commercialization with long lasting outcomes in setting worldwide academic and commercial standards through the invention of novel technologies, such as the microPET.

    The Crump Institute's ultimate objective is to provide biomedicine with new science and technologies to describe, assess, and measure biological function across states from health, through the earliest abnormalities, to frank disease. The new tools and knowledge we generate will accelerate the development of targeted therapies central to the new era of molecular medicine.

  • Ahmanson Translational Imaging DivisionAhmanson Translational Imaging Division

    The Ahmanson Translation Imaging Division is part of the UCLA department of Molecular and Medical Pharmacology. The goal of the division is to address clinical needs by understanding the biology of diseases, and developing diagnostic tools and therapeutics to improve the outcome of patients. The Division faculty, students, postdoctoral fellows and research staff are engaged in imaging research and education, and clinical service in the molecular imaging diagnostics of the biology of disease within the Nuclear Medicine clinical service with conventional and PET/CT imaging.

  • UCLA business of Science CenterUCLA business of Science Center

    The Business of Science Center (BSC) is a training, industry outreach, and business education initiative within the UCLA Department of Molecular and Medical Pharmacology. The BSC is open to all life sciences, engineering, and business graduate students, fellows, and faculty in addition to medical clinicians and residents.

    The BSC currently offers graduate level courses introducing the principals of business and entrepreneurship in technology sectors; practical student experience in identifying, evaluating, and validating the commercial potential of faculty discoveries; and a venue for student engagement with industry professionals. Working closely with faculty inventors and industry professionals, the BSC exposes students to research the commercial potential and provides an opportunity to apply classroom knowledge to real world situations.

The Department of Molecular and Medical Pharmacology (DMMP) is a combined basic science and clinical department. The DMMP integrates mathematics, engineering, physical, biological and medical sciences to achieve together advances that we cannot achieve individually in three overall areas: (1) understanding biology of disease, (2) developing new molecular diagnostics and (3) developing new molecular and cellular therapeutics.

The DMMP is home to the Molecular and Medical Pharmacology Ph.D program, Crump Institute for Molecular Imaging, Ahmanson Translational Imaging Division, containing PET and Nuclear Medicine imaging research and clinical service, and the Business of Science Center.